11.12.2009 • TopicsPetrochemicalsinvestmentLG Chem

$370 Million Petrochemical Investment

South Korea's LG Chem and state-owned China National Offshore Oil Corporation (CNOOC) will invest a total of $370 million to build a petrochemical plant in China by 2011, LG Chem said in a statement. The two companies would each hold a 50 % stake in the plant, in the southern Chinese province of Guangdong, which would produce 150,000 tons of acrylonitrile butadiene styrene (ABS) annually from 2011 and 300,000 tons annually by 2013, the statement said. It said CNOOC and LG Chem, the world's largest ABS producer by market share, planned to market the output in southern China - the country's largest ABS market, accounting for half of the 3.4 million tons consumed in the country - with a sales target of $300 million by 2012 and $600 million by 2014.

The new plant will lift LG Chem's annual production in China to 1 millon tons, and to 1.6 million tons overall, bringing LG Chem's ABS output level with that of Taiwan's Chi Mei Corp , the world's largest producer by capacity. ABS is a thermoplastic used in the production of electrical, electronic and automobile components because of its thermal endurance and electrical properties. Seperately, LG Chem plans to expand an existing ABS plant in Ningbo, southern China to 700,000 tons by 2012 from 580,000 tons. It also produces 600,000 tons per year at a plant in Yeosu, south of Seoul. CNOOC, China's largest offshore oil producer, operates its oil and gas production businesses via listed CNOOC.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Interview

Stability in Motion
Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.

most read

Photo
19.03.2025 • TopicsStrategy

The Future of Demand for Chemicals

The chemical industry is shifting to sustainability-related products, with demand growing 4.5 times faster than conventional ones. Companies must revise their market strategies to capitalize on this opportunity.

Photo
14.05.2025 • TopicsPharma

Pharma Outlook 2025

The environment for pharma in 2025 is diverse and challenging: New treatment options are being brought to market in ever shorter cycles.